Literature DB >> 26474678

Evidence for neuropathic processes in chronic cough.

Akio Niimi1, Kian Fan Chung2.   

Abstract

Chronic cough is a very common symptom for which patients seek medical attention but can often be difficult to manage, because associated causes may remain elusive and treatment of any associated causes does not always provide adequate relief. Current antitussives have limited efficacy and undesirable side-effects. Patients with chronic cough typically describe sensory symptoms suggestive of upper airway and laryngeal neural dysfunction. They often report cough triggered by low-level physical and chemical stimuli supporting the recently emerging concept of 'cough hypersensitivity syndrome'. Chronic cough is a neuropathic condition that could be secondary to sensory nerve damage caused by inflammatory, infective and allergic factors. Mechanisms underlying peripheral and central augmentation of the afferent cough pathways have been identified. Successful treatment of chronic cough with agents used for treating neuropathic pain, such as gabapentin and amitriptyline, would also support this concept. Further research of neuropathic cough may lead to the discovery of more effective antitussives in the future.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amitryptiline; Chronic cough; Cough hypersensitivity syndrome; Gabapentin; Neuropathic pain; Sensory neuropathy

Mesh:

Year:  2015        PMID: 26474678     DOI: 10.1016/j.pupt.2015.10.004

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  7 in total

Review 1.  Cough desensitization treatment: A randomized, sham-controlled pilot trial for patients with refractory chronic cough.

Authors:  Laurie Slovarp; Jane E Reynolds; Emma Bozarth-Dailey; Sarah Popp; Sarah Campbell; Paige Morkrid
Journal:  Respir Med       Date:  2022-01-15       Impact factor: 3.415

2.  Impaired innate immune gene profiling in airway smooth muscle cells from chronic cough patients.

Authors:  Christos Rossios; Stelios Pavlidis; David Gibeon; Sharon Mumby; Andrew Durham; Oluwaseun Ojo; Daniel Horowitz; Matt Loza; Fred Baribaud; Navin Rao; Kian Fan Chung; Ian M Adcock
Journal:  Biosci Rep       Date:  2017-11-15       Impact factor: 3.840

3.  Supraglottic Botulinum Toxin Improves Symptoms in Patients with Laryngeal Sensory Dysfunction Manifesting as Abnormal Throat Sensation and/or Chronic Refractory Cough.

Authors:  Daniel Novakovic; Meet Sheth; Thomas Stewart; Katrina Sandham; Catherine Madill; Antonia Chacon; Duy Duong Nguyen
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

Review 4.  The Prospect for Potent Sodium Voltage-Gated Channel Blockers to Relieve an Excessive Cough.

Authors:  M Brozmanova; N Pavelkova
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

5.  Cough Reflex Sensitivity in Asthmatic Children.

Authors:  P Kunc; J Fabry; M Lucanska; T Zatko; M Grendar; R Pecova
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

Review 6.  Cough Hypersensitivity Syndrome: A Few More Steps Forward.

Authors:  Woo Jung Song; Alyn H Morice
Journal:  Allergy Asthma Immunol Res       Date:  2017-09       Impact factor: 5.764

Review 7.  Update on Cerebellar Ataxia with Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS).

Authors:  Mathieu Dupré; Ruben Hermann; Caroline Froment Tilikete
Journal:  Cerebellum       Date:  2020-10-04       Impact factor: 3.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.